Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87


Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients.

Woods KL, Johnson JR, Padkowsky S, Mariano N, Colon-Urban R, Hassanein M, Wehbeh W, Johnston BD, Clabots C, Zahid S, Urban C.

Antimicrob Agents Chemother. 2012 Apr;56(4):2209-10. doi: 10.1128/AAC.00003-12. Epub 2012 Jan 17. No abstract available.


Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region.

Pitout JD, Gregson DB, Church DL, Elsayed S, Laupland KB.

J Clin Microbiol. 2005 Jun;43(6):2844-9.


Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.

Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP.

J Antimicrob Chemother. 2008 Aug;62(2):284-8. doi: 10.1093/jac/dkn181. Epub 2008 May 2.


CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia.

Ruppé E, Hem S, Lath S, Gautier V, Ariey F, Sarthou JL, Monchy D, Arlet G.

Emerg Infect Dis. 2009 May;15(5):741-8. doi: 10.3201/eid1505.071299.


Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore DM.

J Antimicrob Chemother. 2004 Oct;54(4):735-43. Epub 2004 Sep 3.


CTX-M-1-related extended-spectrum beta-lactamases producing Escherichia coli: so far a sporadic event in Western Austria.

Prelog M, Fille M, Prodinger W, Grif K, Brunner A, Würzner R, Zimmerhackl LB.

Infection. 2008 Aug;36(4):362-7. doi: 10.1007/s15010-008-7309-7. Epub 2008 Jun 21.


Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.

Mendonça N, Leitão J, Manageiro V, Ferreira E, Caniça M.

Antimicrob Agents Chemother. 2007 Jun;51(6):1946-55. Epub 2007 Mar 19.


Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients.

Brigante G, Luzzaro F, Perilli M, Lombardi G, Colì A, Rossolini GM, Amicosante G, Toniolo A.

Int J Antimicrob Agents. 2005 Feb;25(2):157-62.


CTX-M-3 and CTX-M-15 extended-spectrum beta-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria.

Ramdani-Bouguessa N, Mendonça N, Leitão J, Ferreira E, Tazir M, Caniça M.

J Clin Microbiol. 2006 Dec;44(12):4584-6. Epub 2006 Sep 20.


Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.

Kariuki S, Revathi G, Corkill J, Kiiru J, Mwituria J, Mirza N, Hart CA.

J Infect Dev Ctries. 2007 Dec 1;1(3):257-62.


CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.

Celik AD, Yulugkural Z, Kuloglu F, Eroglu C, Torol S, Vahaboğlu H, Akata F.

J Microbiol Immunol Infect. 2010 Apr;43(2):163-7. doi: 10.1016/S1684-1182(10)60026-6.


CTX-M-type beta-lactamases affect community Escherichia coli treatment, Greece.

Pournaras S, Ikonomidis A, Sofianou D, Tsakris A, Maniatis AN.

Emerg Infect Dis. 2004 Jun;10(6):1163-4. No abstract available.


Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.

Ho PL, Poon WW, Loke SL, Leung MS, Chow KH, Wong RC, Yip KS, Lai EL, Tsang KW; COMBAT study group.

J Antimicrob Chemother. 2007 Jul;60(1):140-4. Epub 2007 May 11.


Detection of a novel variant bla(CTX-M-3) extended spectrum beta-lactamase gene in a community-acquired Escherichia coli isolate.

Pournaras S, Tsakris A, Ikonomidis A, Markogiannakis A, Kristo I, Maniatis AN.

Scand J Infect Dis. 2006;38(3):213-6.


Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.

Peirano G, Costello M, Pitout JD.

Int J Antimicrob Agents. 2010 Jul;36(1):19-23. doi: 10.1016/j.ijantimicag.2010.02.016. Epub 2010 Mar 31.


Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region.

Vranes J, Marijan T, Bedenic B, Mlinaric-Dzepina A, Katic S, Kalenic S.

Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S19-24. Epub 2007 Oct 23.


CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.

Dubois V, De Barbeyrac B, Rogues AM, Arpin C, Coulange L, Andre C, M'zali F, Megraud F, Quentin C.

J Antimicrob Chemother. 2010 Jul;65(7):1368-71. doi: 10.1093/jac/dkq153. Epub 2010 May 13.


Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities.

Urban C, Mariano N, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, Colon-Urban R, Johnston B, Johnson JR, Rahal JJ.

Diagn Microbiol Infect Dis. 2010 Apr;66(4):402-6. doi: 10.1016/j.diagmicrobio.2009.11.012.


Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain.

Bou G, Cartelle M, Tomas M, Canle D, Molina F, Moure R, Eiros JM, Guerrero A.

J Clin Microbiol. 2002 Nov;40(11):4030-6.

Items per page

Supplemental Content

Support Center